Alfasigma USA Reintroduces IBS-C Drug Zelnorm to U.S. Market
13 Sep 2019 //
BIOSPACE
Alfasigma USA Announces ZELNORM™ for Irritable Bowel Syndrome with Constipation
16 Aug 2019 //
PHARMACEUTICALDAILY
13 Sep 2019 //
BIOSPACE
16 Aug 2019 //
PHARMACEUTICALDAILY